175 results
·
17ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·ProstaLund CoreTherm System Microwave Thermotherapy for BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE SFA/PPA VASCULAR STENT SYSTEM
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·PROSTALUND CORETHERM SYSTEM MICROWAVE THERMOTHERAPY FOR BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOT THE TREATMENT OF BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE VASCULAR STENT SYSTEM-SFA AND PPA
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE VASCULAR STENT SYSTEM-SFA AND PPA
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE VASCULAR STENT SYSTEM - SFA AND PPA
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE VASCULAR STENT SYSTEM- SFA AND PPA
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·COMPLETE SE VASCULAR STENT SYSTEM-SFA AND PPA
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
FDA Pre-Market Approval
FDA Class 3
·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH
Stent, Superficial Femoral Artery
FDA Pre-Market Approval
FDA Class 3
·MEDTRONIC VASCULAR COMPLETE SE VASCULAR STENT SYSTEM SFA and PPA